Here are relevant reports on : hedge-fund-administration-market
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030
The global dental anesthetics market, valued at US$1.43 billion in 2024, stood at US$1.48 billion in 2025 and is projected to advance at a resilient CAGR of 4.0% from 2025 to 2030, culminating in a forecasted valuation of US$1.80 billion by the end of the period. Several factors are driving the global market for dental anesthetics
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Europe Enteral Feeding Devices Market by Type [Tubes(Nasal, Gastrostomy), Pumps {Portable, Stationary}, Enteral Syringe, Administration Set, Consumable], Insertion Method, Age Group (Neonate, Pediatric, Geriatric), Application, End user- Forecast to 2032
The Europe enteral feeding device market, valued at USD 0.85 billion in 2025, stood at USD 0.88 billion in 2026 and is projected to advance at a resilient CAGR of 4.0% from 2026 to 2032, culminating in a forecasted valuation of USD 1.11 billion by the end of the period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Pharmaceuticals Market by Animal Type (Dogs, Cats, Horses), Route of Administration (Oral, Injectable, Topical), Indication (Antibiotics, Parasiticides), Distribution Channel (Veterinary Hospitals & Clinics) & Region - Global Forecasts to 2027
The global companion animal pharmaceuticals market in terms of revenue was estimated to be worth $14.4 billion in 2022 and is poised to reach $19.6 billion by 2027, growing at a CAGR of 6.3% from 2022 to 2027. Major players operating in the market Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), Ceva Santé Animale (France), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals plc (UK) are some of the market players.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Asia Pacific Enteral Feeding Devices Market, by Type (Administration sets, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Respiratory), End User - Forecast to 2032
The Asia Pacific enteral feeding device market, valued at USD 0.76 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2032, culminating in a forecasted valuation of USD 1.20 billion by the end of the period. In the Asia Pacific enteral feeding devices market, the growth of enteral feeding tubes is primarily attributed to the incidence of diseases such as cancer, stroke, neurological disorders, and gastrointestinal diseases that often lead to swallowing difficulties and require prolonged nutrition support.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pain Patch Market by Type (Opioid & Non-Opioid), By Mode of Administration (Metered Dose & Microneedle Patches) and by Therapeutic Use (Pain relief, Anaesthesia, Cough Suppression, Smoking Cessation) - Global Forecast to 2023
The global Pain Patch market is expected to reach USD 30.95 billion by 2023 from USD 24.25 billion in 2018, growing at a CAGR of 5.0%. Rising usage of opioids in non-cancer conditions and favourable reimbursement policies, increasing research and development in this field, favourable reimbursement facilities for palliative care in North American and European countries are some factors also promoting growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Europe Identity and Access Management (IAM) Market by Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type (Human, Non-Human Identity) - Forecast to 2030
The size of the identity and access management (IAM) market in Europe is projected to grow from USD 6.09 billion in 2025 to USD 9.79 billion by 2030 at a CAGR of 10.0% during the forecast period. The Key Players Microsoft (US), Thales (France), Evidian (France), Ping Identity (US), IBM (US), Okta (US), Oracle (US), iC Consult (Germany), IN Groupe (France), Ubisecure (Finland), CyberArk (US), HID Global (US), Authentik (US), cidaas (Germany), Curity (Sweden), Traxion (Netherlands), Elimity (Belgium), and Omada (Denmark)
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
US Pharmaceutical Drug Delivery Market by Route of Administration [Oral (Tablet, Capsule), Injectable, Topical (Cream, Transdermal, Suppositories), Ocular, Nasal, Transmucosal, Implantable], Application (Cancer, Diabetes), Care Setting - Forecast to 2031
The US pharmaceutical drug delivery market, valued at US$0.91 billion in 2025, stood at US$0.94 billion in 2026 and is projected to advance at a resilient CAGR of 5.8% from 2026 to 2031, culminating in a forecasted valuation of US$1.24 billion by the end of the period. The market growth trend is fueled by several factors. One of the primary drivers is the quick and extensive rise of biologics and biosimilars, necessitating advanced injectable and large-volume delivery systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
